Amedeo Smart

Free Medical Literature Service


 

Amedeo

Prostate Cancer

  Free Subscription

Articles published in
JAMA
    August 2026
  1. ELLIS RJ, Pugh SL, Yu JB, Feng FY, et al
    Stereotactic Body Radiotherapy vs Moderately Hypofractionated IMRT for Localized Intermediate-Risk Prostate Cancer: A Randomized Clinical Trial.
    JAMA. 2026 Aug 13. doi: 10.1001/jama.2026.12627.
    >> Share


  2. Stereotactic Body Radiotherapy vs Moderately Hypofractionated IMRT for Localized Intermediate-Risk Prostate Cancer: Research Summary.
    JAMA. 2026 Aug 13:e2612679. doi: 10.1001/jama.2026.12679.
    >> Share

  3. COSENZA A, Nguyen DD, Qian Z, Bernardino R, et al
    Focal Therapy for Prostate Cancer.
    JAMA. 2026 Aug 13. doi: 10.1001/jama.2026.12411.
    >> Share

  4. LEE G, Bihn JR, Culnan JM, La J, et al
    Active Surveillance Use for Favorable-Risk Prostate Cancer in a Veterans Affairs Population.
    JAMA. 2026 Aug 13. doi: 10.1001/jama.2026.13471.
    >> Share

    January 2026
  5. NG ABCD, Asif A, Kasivisvanathan V
    Biparametric vs Multiparametric MRI for Diagnosis of Prostate Cancer-Reply.
    JAMA. 2026 Jan 15. doi: 10.1001/jama.2025.22866.
    >> Share

  6. LOMBARDO R, Lorenti C, De Nunzio C
    Biparametric vs Multiparametric MRI for Diagnosis of Prostate Cancer.
    JAMA. 2026 Jan 15. doi: 10.1001/jama.2025.22869.
    >> Share

  7. PERERA MOLLIGODA ARACHCHIGE AS
    Biparametric vs Multiparametric MRI for Prostate Cancer Diagnosis.
    JAMA. 2026 Jan 15. doi: 10.1001/jama.2025.22872.
    >> Share

  8. LIN HC, Chen HT, Chang CM
    Biparametric vs Multiparametric MRI for Prostate Cancer Diagnosis.
    JAMA. 2026 Jan 15. doi: 10.1001/jama.2025.22863.
    >> Share

    September 2025
  9. NG ABCD, Asif A, Agarwal R, Panebianco V, et al
    Biparametric vs Multiparametric MRI for Prostate Cancer Diagnosis: The PRIME Diagnostic Clinical Trial.
    JAMA. 2025 Sep 10:e2513722. doi: 10.1001/jama.2025.13722.
    >> Share

    July 2025
  10. VOELKER R
    What Is Prostate Cancer?
    JAMA. 2025 Jul 24. doi: 10.1001/jama.2025.10177.
    >> Share

  11. CATTO JWF, Murphy D, Loeb S
    Microultrasonography-Guided vs MRI-Guided Biopsy for Prostate Cancer Diagnosis.
    JAMA. 2025 Jul 14. doi: 10.1001/jama.2025.7941.
    >> Share

  12. KINNAIRD A, Klotz L
    Microultrasonography-Guided vs MRI-Guided Biopsy for Prostate Cancer Diagnosis-Reply.
    JAMA. 2025 Jul 14. doi: 10.1001/jama.2025.7944.
    >> Share

  13. MIAO Y, Zhao K, Shang A
    Complexity of Prostate Cancer.
    JAMA. 2025 Jul 9. doi: 10.1001/jama.2025.7196.
    >> Share

  14. RAYCHAUDHURI R, Lin DW, Montgomery RB
    Complexity of Prostate Cancer-Reply.
    JAMA. 2025 Jul 9. doi: 10.1001/jama.2025.7193.
    >> Share

    March 2025
  15. KINNAIRD A, Luger F, Cash H, Ghai S, et al
    Microultrasonography-Guided vs MRI-Guided Biopsy for Prostate Cancer Diagnosis: The OPTIMUM Randomized Clinical Trial.
    JAMA. 2025 Mar 23:e253579. doi: 10.1001/jama.2025.3579.
    >> Share

  16. RAYCHAUDHURI R, Lin DW, Montgomery RB
    Prostate Cancer: A Review.
    JAMA. 2025 Mar 10. doi: 10.1001/jama.2025.0228.
    >> Share

    November 2024
  17. AJJAWI I, Loeb S, Cooperberg MR, Catalona WJ, et al
    Active Surveillance or Watchful Waiting for Intermediate-Risk Prostate Cancer, 2010-2020.
    JAMA. 2024 Nov 20:e2420580. doi: 10.1001/jama.2024.20580.
    >> Share

    August 2024
  18. TURNER EL, Metcalfe C, Martin RM
    PSA Screening and Prostate Cancer Mortality-Reply.
    JAMA. 2024 Aug 15. doi: 10.1001/jama.2024.13809.
    >> Share

  19. GOLDSTEIN MR, Mascitelli L
    PSA Screening and Prostate Cancer Mortality.
    JAMA. 2024 Aug 15. doi: 10.1001/jama.2024.13806.
    >> Share

  20. D'AMICO AV
    PSA Screening and Prostate Cancer Mortality.
    JAMA. 2024 Aug 15. doi: 10.1001/jama.2024.13803.
    >> Share

    July 2024
  21. NIK-AHD F, De Hoedt AM, Butler C, Anger JT, et al
    Prostate-Specific Antigen Values in Transgender Women Receiving Estrogen.
    JAMA. 2024;332:335-337.
    >> Share

    June 2024
  22. FENG X, Zahed H, Onwuka J, Callister MEJ, et al
    Cancer Stage Compared With Mortality as End Points in Randomized Clinical Trials of Cancer Screening: A Systematic Review and Meta-Analysis.
    JAMA. 2024;331:1910-1917.
    >> Share

    May 2024
  23. NEWCOMB LF, Schenk JM, Zheng Y, Liu M, et al
    Long-Term Outcomes in Patients Using Protocol-Directed Active Surveillance for Prostate Cancer.
    JAMA. 2024 May 30. doi: 10.1001/jama.2024.6695.
    >> Share

  24. HARRIS E
    Urine-Based Test Could Help Identify Aggressive Prostate Cancer.
    JAMA. 2024 May 17. doi: 10.1001/jama.2024.8424.
    >> Share

  25. HARRIS E
    Prostate Cancer Cases Might Rise to 3 Million Globally by 2040.
    JAMA. 2024 May 3. doi: 10.1001/jama.2024.6729.
    >> Share

    April 2024
  26. BAROCAS DA, Al Hussein Al Awamlh B, Koyama T
    Outcomes Following Localized Prostate Cancer Treatment-Reply.
    JAMA. 2024 Apr 29. doi: 10.1001/jama.2024.5492.
    >> Share

  27. HUANG TB, Ding XF
    Outcomes Following Localized Prostate Cancer Treatment.
    JAMA. 2024 Apr 29. doi: 10.1001/jama.2024.5486.
    >> Share

  28. CORNU JN
    Outcomes Following Localized Prostate Cancer Treatment.
    JAMA. 2024 Apr 29. doi: 10.1001/jama.2024.5489.
    >> Share

  29. AUVINEN A, Tammela TLJ, Mirtti T, Lilja H, et al
    Prostate Cancer Screening With PSA, Kallikrein Panel, and MRI: The ProScreen Randomized Trial.
    JAMA. 2024 Apr 6:e243841. doi: 10.1001/jama.2024.3841.
    >> Share

  30. TOSOIAN JJ, Penson DF, Chinnaiyan AM
    A Pragmatic Approach to Prostate Cancer Screening.
    JAMA. 2024 Apr 6. doi: 10.1001/jama.2024.4089.
    >> Share

  31. MARTIN RM, Turner EL, Young GJ, Metcalfe C, et al
    Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality: A Secondary Analysis of the CAP Randomized Clinical Trial.
    JAMA. 2024 Apr 6:e244011. doi: 10.1001/jama.2024.4011.
    >> Share

    January 2024
  32. AL HUSSEIN AL AWAMLH B, Wallis CJD, Penson DF, Huang LC, et al
    Functional Outcomes After Localized Prostate Cancer Treatment.
    JAMA. 2024;331:302-317.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016